MARKET

JAGX

JAGX

Jaguar Health Inc
NASDAQ
0.9792
+0.0793
+8.81%
Opening 14:42 02/18 EST
OPEN
0.9000
PREV CLOSE
0.8999
HIGH
1.000
LOW
0.8617
VOLUME
422.90K
TURNOVER
--
52 WEEK HIGH
21.60
52 WEEK LOW
0.7786
MARKET CAP
12.82M
P/E (TTM)
-0.0492
1D
5D
1M
3M
1Y
5Y
1D
Jaguar Health extends collaboration with Streeterville
TipRanks · 6h ago
Jaguar Health extends collaboration with Streeterville to develop P-300
TipRanks · 6h ago
JAGUAR HEALTH-EXTENDS COLLABORATION FOR POSSIBLE TROPICAL DISEASE PRIORITY REVIEW VOUCHER AND CHOLERA INDICATION FOR NP-300
Reuters · 6h ago
Weekly Report: what happened at JAGX last week (0210-0214)?
Weekly Report · 1d ago
Weekly Report: what happened at JAGX last week (0203-0207)?
Weekly Report · 02/10 11:51
Jaguar Health announces first SBS-IF patient dosed in IIT trial of crofelemer
TipRanks · 02/03 14:41
Weekly Report: what happened at JAGX last week (0127-0131)?
Weekly Report · 02/03 11:57
Jaguar's Mytesi could be used to treat GI side effects of GLP-1 weight loss drugs
Seeking Alpha · 01/29 14:55
More
About JAGX
Jaguar Health, Inc. is a commercial-stage pharmaceuticals company. The Company is focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress. It operates through two segments: human health and animal health. The animal health segment is focused on developing and commercializing prescription and non-prescription products for companion and production animals. The human health segment is focused on developing and commercializing of human products and the ongoing commercialization of Mytesi, which is used for the symptomatic relief of non-infectious diarrhea in adults with human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS) on antiretroviral therapy. The Canalevia-CA1 is for the treatment of chemotherapy-induced diarrhea (CID) in dogs. Its subsidiary Napo Pharmaceuticals, Inc. focuses on developing and commercializing human prescription pharmaceuticals.

Webull offers Jaguar Health Inc stock information, including NASDAQ: JAGX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, JAGX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading JAGX stock methods without spending real money on the virtual paper trading platform.